The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts

Exclusion Criteria

• •Clinical Criteria:
• •Myocardial infarction with documented total CK-MB \> 2 times the upper limit of normal within the past 24 hours, or currently experiencing an acute myocardial infarction.
• •Undergone cardiac surgery within the past 60 days.
• •A planned invasive surgical procedure within 30 days.
• •The lesion(s) is in an SVG that is less than 2 months post-implant.
• •Left ventricular ejection fraction \< 20%.
• •A stroke or transient ischemic neurological attack (TIA) within the past 2 months.
• •Angiographic Criteria:
• •The lesion(s) is in an arterial conduit.
• •Lesion is within 10 mm of the proximal anastomosis.
• •More than two native lesions \[in addition to the SVG lesion(s)\] that need to be treated at the index procedure.
• •More than two SVGs that need to be treated at the index procedure.
• •Chronic total occlusion of a target lesion.
• •The SVG lesion(s) requires treatment with a large device other than PTCA prior to stent placement (such as, but not limited to, directional coronary atherectomy, excimer laser, rotational atherectomy, rheolytic thrombectomy or brachytherapy).